Open Access

Update on radionuclide therapy in oncology (Review)

  • Authors:
    • Cornelia Nitipir
    • Dana Niculae
    • Cristina Orlov
    • Maria Alexandra Barbu
    • Bogdan Popescu
    • Ana Maria Popa
    • Anca Mihaela Stoian Pantea
    • Adina Elena Stanciu
    • Bianca Galateanu
    • Octav Ginghina
    • Georgios Z. Papadakis
    • Boris N. Izotov
    • Demetrios A. Spandidos
    • Aristides M. Tsatsakis
    • Carolina Negrei
  • View Affiliations

  • Published online on: October 5, 2017     https://doi.org/10.3892/ol.2017.7141
  • Pages:7011-7015
  • Copyright: © Nitipir et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

0

Abstract

Unstable isotopes and their capacity to emit ionizing radiation have been employed in clinical practice not only for diagnostic, but also for therapeutic purposes, with significant contribution in several fields of medicine and primarily in the management of oncologic patients. Their efficacy is associated with their ability to provide the targeted delivery of ionizing radiation for a determined duration. These compounds can be used for curative or palliative treatment, as well as for a diagnostic‑therapeutic (theranostic) approach. This review summarises the most recent trends in radionuclide treatment for several malignancies, including prostate cancer, neuroendocrine tumours, and hematological and thyroid malignancies, in which radionuclide‑based therapies have been employed with high effectiveness.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nitipir, C., Niculae, D., Orlov, C., Barbu, M.A., Popescu, B., Popa, A.M. ... Negrei, C. (2017). Update on radionuclide therapy in oncology (Review). Oncology Letters, 14, 7011-7015. https://doi.org/10.3892/ol.2017.7141
MLA
Nitipir, C., Niculae, D., Orlov, C., Barbu, M. A., Popescu, B., Popa, A. M., Stoian Pantea, A. M., Stanciu, A. E., Galateanu, B., Ginghina, O., Papadakis, G. Z., Izotov, B. N., Spandidos, D. A., Tsatsakis, A. M., Negrei, C."Update on radionuclide therapy in oncology (Review)". Oncology Letters 14.6 (2017): 7011-7015.
Chicago
Nitipir, C., Niculae, D., Orlov, C., Barbu, M. A., Popescu, B., Popa, A. M., Stoian Pantea, A. M., Stanciu, A. E., Galateanu, B., Ginghina, O., Papadakis, G. Z., Izotov, B. N., Spandidos, D. A., Tsatsakis, A. M., Negrei, C."Update on radionuclide therapy in oncology (Review)". Oncology Letters 14, no. 6 (2017): 7011-7015. https://doi.org/10.3892/ol.2017.7141